Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Polyethylene Terephthalate
98%
Pediatrics
96%
Neoplasm
83%
Fluorodeoxyglucose F 18
60%
Oncology
48%
Cancer
36%
Radiation Therapy
33%
Diagnostic Imaging
32%
Positron Emission Tomography
25%
Computer Assisted Tomography
25%
Arm
24%
Low Drug Dose
23%
Hodgkin's Lymphoma
21%
Breast Cancer
21%
Positron Emission Tomography - Magnetic Resonance Imaging
21%
Treatment Response
21%
Diseases
18%
Magnetic Resonance Imaging
17%
Image Quality
16%
Gene Mutation
14%
Recurrent Disease
14%
Clinical Trial
14%
Childhood Cancer
13%
Gallium 68
13%
Mitogen-Activated Protein Kinase
13%
Biological Marker
12%
Injury
12%
Cervical Cancer
12%
Diagnostic Accuracy
12%
Single Photon Emission Computed Tomography-Computed Tomography
12%
Technetium-99
12%
Metastatic Carcinoma
11%
Progression Free Survival
11%
Molecularly Targeted Therapy
11%
Neuroendocrine Tumor
10%
Diffuse Large B-Cell Lymphoma
10%
Gynecological Oncology
10%
DNA Template
10%
Kidney Tumour
10%
Thyroid Cancer
10%
Selumetinib
10%
Visceral Fat
10%
Disease Activity
10%
Hematopoietic Stem Cell Transplantation
10%
Dual Energy Computed Tomography
10%
Epidermal Growth Factor Receptor 2
10%
Preoperative Systemic Therapy
10%
Gamma Urogastrone
10%
Magnetic Resonance Enterography
10%
Keyphrases
Tumor
76%
Positron Emission Tomography-computed Tomography (PET-CT)
75%
Pediatric
53%
Oncology
38%
Diagnostic Imaging
32%
PET Image
31%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
28%
Metabolic Tumor Volume
27%
Oncologic
25%
18F-fluorodeoxyglucose (18F-FDG)
25%
Quantitative PET
24%
FDG Uptake
24%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
24%
Total Lesion Glycolysis
21%
Objective Task-based Evaluation
21%
Imaging Recommendations
21%
Observer Performance
21%
PET-MRI
21%
Older Adults
21%
Pictorial Review
21%
Phase II Study
21%
Clinical Practice
20%
18F-FDG PET-CT
19%
Image Quality
19%
Positron Emission Tomography
18%
Segmentation Method
17%
Radiation Dose
17%
High Risk
16%
FDG-PET Scan
16%
Multicenter Clinical Trial
16%
Confidence Interval
16%
Working Diagnosis
16%
Imaging Studies
16%
PET Segmentation
15%
Genetic Modification
14%
Dice Similarity Coefficient
14%
Radiation Therapy
14%
Pediatric Patients
14%
Hodgkin Lymphoma
14%
Deep Learning
14%
Mitogen-activated Protein Kinase
13%
Lymphoma
13%
Metabolic
12%
Pediatric Oncology
12%
SPECT-CT
12%
Clinical Trial Data
12%
Imaging Standards
12%
Clinically Significant
12%
Imaging Methods
12%
Response Predictors
12%